Alivus Life Sciences

Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting.

01 Dec, 2025 | 04:59pm • Source: BSE

Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting.

01 Dec, 2025 | 04:59pm • Source: BSE

Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting

27 Nov, 2025 | 08:53pm • Source: BSE

Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting.

14 Nov, 2025 | 02:29pm • Source: BSE

Alivus Life Sciences Limited has informed the Exchange about Weblink of Recording of Earnings Call Q2 FY2026

07 Nov, 2025 | 03:25pm • Source: NSE

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we...

07 Nov, 2025 | 03:17pm • Source: BSE

Enclosing herewith Investor Presentation - Q2 FY 2025-26.

06 Nov, 2025 | 07:28pm • Source: BSE

Press Release - Q2 FY 2026 Financials

06 Nov, 2025 | 06:55pm • Source: BSE

Please find enclosed Unaudited Financial Results for the Second quarter and Half Year ended September 30, 2025.

06 Nov, 2025 | 06:44pm • Source: BSE

Enclosed please find herewith the details of Earnings Call slated for Friday, November 7, 2025 from 8:30 a.m. to 9:30 a.m. (IST), for your information...

30 Oct, 2025 | 03:46pm • Source: BSE

Intimation of closure of trading window from September 30, 2025 to November 08, 2025 (both days inclusive) for the purpose of approval of unaudited financial...

29 Oct, 2025 | 05:40pm • Source: BSE

Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider...

29 Oct, 2025 | 05:35pm • Source: BSE

Alivus Life Sciences Ltd has informed BSE regarding the details of Notice/Order received by the Company from Office of The Gujarat Pollution Control Board ('GPCB').

20 Oct, 2025 | 09:45am • Source: BSE

India Rating upgrades Alivus Life Sciences''s Bank loan facilities to ''IND AA'' ; Outlook stable.

16 Sep, 2025 | 03:37pm • Source: BSE

Please find attached herewith intimation with respect to Appointment of Secretarial Auditor.

08 Sep, 2025 | 08:47pm • Source: BSE

Please find attached herewith Scrutinizers Report.

08 Sep, 2025 | 08:41pm • Source: BSE

Proceedings of the 14th Annual General Meeting (AGM) of Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) held on 08th September, 2025

08 Sep, 2025 | 08:35pm • Source: BSE

Change in Corporate Office address.

03 Sep, 2025 | 05:44pm • Source: BSE

Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting

26 Aug, 2025 | 11:34am • Source: BSE

Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Investors/Analyst Meeting

21 Aug, 2025 | 03:16pm • Source: BSE